El-Hariri S, Saleh F, Moghnieh W, Sokhn E
JAC Antimicrob Resist. 2023; 5(3):dlad074.
PMID: 37305848
PMC: 10251202.
DOI: 10.1093/jacamr/dlad074.
Ambrose P, Bhavnani S, Andes D, Bradley J, Flamm R, Pogue J
Open Forum Infect Dis. 2020; 7(7):ofaa084.
PMID: 32667364
PMC: 7336562.
DOI: 10.1093/ofid/ofaa084.
Sajjad S, Uzair B, Shaukat A, Jamshed M, Leghari S, Ismail M
IET Nanobiotechnol. 2019; 13(4):435-440.
PMID: 31171749
PMC: 8676072.
DOI: 10.1049/iet-nbt.2018.5415.
Lee B, Kang S, Kang H, Yang N, Kang H, Ha I
Infect Chemother. 2014; 45(4):415-21.
PMID: 24475355
PMC: 3902812.
DOI: 10.3947/ic.2013.45.4.415.
Lachmayr K, Kerkhof L, DiRienzo A, Cavanaugh C, Ford T
Appl Environ Microbiol. 2008; 75(1):203-11.
PMID: 18997031
PMC: 2612200.
DOI: 10.1128/AEM.01254-08.
TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).
Robin F, Delmas J, Chanal C, Sirot D, Sirot J, Bonnet R
Antimicrob Agents Chemother. 2005; 49(11):4443-7.
PMID: 16251281
PMC: 1280126.
DOI: 10.1128/AAC.49.11.4443-4447.2005.
Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests.
Linscott A, Brown W
J Clin Microbiol. 2005; 43(3):1081-5.
PMID: 15750065
PMC: 1081251.
DOI: 10.1128/JCM.43.3.1081-1085.2005.
Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units.
Wu T, Chia J, Su L, Kuo A, Chu C, Chiu C
J Clin Microbiol. 2003; 41(10):4836-8.
PMID: 14532236
PMC: 254364.
DOI: 10.1128/JCM.41.10.4836-4838.2003.
Extended-spectrum beta-lactamases in Ireland, including a novel enzyme, TEM-102.
Morris D, OHare C, Glennon M, Maher M, Corbett-Feeney G, Cormican M
Antimicrob Agents Chemother. 2003; 47(8):2572-8.
PMID: 12878521
PMC: 166109.
DOI: 10.1128/AAC.47.8.2572-2578.2003.
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.
Kim Y, Pai H, Lee H, Park S, Choi E, Kim J
Antimicrob Agents Chemother. 2002; 46(5):1481-91.
PMID: 11959586
PMC: 127143.
DOI: 10.1128/AAC.46.5.1481-1491.2002.
Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.
Martinez-Martinez L, Pascual A, Suarez A, Tran J, Benedi V, Jacoby G
Antimicrob Agents Chemother. 1999; 43(7):1669-73.
PMID: 10390220
PMC: 89341.
DOI: 10.1128/AAC.43.7.1669.
Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.
Wu S, Dornbusch K, Kronvall G, Norgren M
Antimicrob Agents Chemother. 1999; 43(6):1350-7.
PMID: 10348751
PMC: 89277.
DOI: 10.1128/AAC.43.6.1350.
Transferable resistance to cefotaxime, ceftazidime, and aztreonam and production of extended-spectrum beta-lactamase in a strain of Salmonella enteritidis.
Blahova J, Kralikova K, Krcmery Sr V, Kubonova K
Eur J Clin Microbiol Infect Dis. 1997; 16(9):703-5.
PMID: 9352270
DOI: 10.1007/BF01708567.
Is it important to identify extended-spectrum beta-lactamase-producing isolates?.
Bush K
Eur J Clin Microbiol Infect Dis. 1996; 15(5):361-4.
PMID: 8793392
DOI: 10.1007/BF01690090.
TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.
Bradford P, Jacobus N, Bhachech N, Bush K
Antimicrob Agents Chemother. 1996; 40(1):260-2.
PMID: 8787920
PMC: 163097.
DOI: 10.1128/AAC.40.1.260.
Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
Vanjak D, Muller-Serieys C, Picard B, Bergogne-Berezin E, Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis. 1995; 14(11):972-8.
PMID: 8654448
DOI: 10.1007/BF01691379.
Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.
Payne D, Cramp R, Winstanley D, Knowles D
Antimicrob Agents Chemother. 1994; 38(4):767-72.
PMID: 8031044
PMC: 284540.
DOI: 10.1128/AAC.38.4.767.
New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak.
Morosini M, Canton R, Negri M, Perez-Diaz J, Baquero F, Blazquez J
Antimicrob Agents Chemother. 1995; 39(2):458-61.
PMID: 7726515
PMC: 162560.
DOI: 10.1128/AAC.39.2.458.
A functional classification scheme for beta-lactamases and its correlation with molecular structure.
Bush K, Jacoby G, Medeiros A
Antimicrob Agents Chemother. 1995; 39(6):1211-33.
PMID: 7574506
PMC: 162717.
DOI: 10.1128/AAC.39.6.1211.
Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.
Petit A, Sirot D, Chanal C, Sirot J, Labia R, Gerbaud G
Antimicrob Agents Chemother. 1988; 32(5):626-30.
PMID: 3293523
PMC: 172242.
DOI: 10.1128/AAC.32.5.626.